Novo to partner with Anthropic on drug discovery efforts

This collaboration signals a major pivot for pharmaceutical giants toward leveraging generative AI to compress the multi-year drug development timeline. By integrating Anthropic's advanced large language models into its R&D pipeline, Novo Nordisk aims to decode complex biological data and identify novel therapeutic targets at unprecedented speeds.